Proteinea
- Biotech or pharma, therapeutic R&D
Proteinea is advancing the next generation of antibodies through unlocking the full therapeutic potential of the Fc domain. Our AI-enabled platform combines proprietary Fc datasets with structure-function modeling and knowledge-based variant generation, to engineer novel Fc scaffolds that enable superior efficacy, safety, and convenience. Our approach allows for fine-tuned control over receptor affinity, immune activity, and biophysical properties, opening new frontiers in precision antibody functionality.